Annotated Medicine and Device Lists


Linezolid

This medicine is present in:

List Section Observation
Bahamas. Drug Formulary 7.01.02. Other Antibacterials No observations

This medicine is present in:

List Section Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Antibiotics Miscellaneous No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. No observations

This medicine is present in:

List Section Observation
Bahamas. Drug Formulary 7.01.02. Other Antibacterials No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.2.3. Reserve group antibiotics No observations

This medicine is present in:

List Section Observation
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 03.02. ANTIBACTERIANOS No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.2.3. Reserve group antibiotics No observations
WHO Model List of Essential Medicines (2021) 6.2.5. Antituberculosis medicines No observations
Haiti. National List of Essential Medicines 06.02.02 Other Antibacterials No observations

This medicine is present in:

List Section Observation
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations

This medicine is present in:

List Section Observation
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
El Salvador - 2019 ANTIBACTERIANOS Others observations:
In resistance to vancomycin
Haiti. National List of Essential Medicines 06.02.02 Other Antibacterials No observations
PAHO Strategic Fund Medicine List 2.4. Antiberculosis med. 2nd line No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.2.3. Reserve group antibiotics No observations
Haiti. National List of Essential Medicines 06.02.02 Other Antibacterials No observations
PAHO Strategic Fund Medicine List 2.4. Antiberculosis med. 2nd line Others observations:
Procurement of this medicine through the Strategic Fund should be limited for use according to WHO recommended M/XDR-TB regimen in patients for whom there are few or no treatments available. Patients receiving this medicine should be monitored for potential adverse events or related toxicities through national pharmacovigilance programs and data from the WHO Programme for International Drug Monitoring (UPPSALA).

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.2.3. Reserve group antibiotics No observations
WHO Model List of Essential Medicines (2021) 6.2.5. Antituberculosis medicines No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Antibiotics Miscellaneous No observations
Bolivia. Lista Nacional de Medicamentos Esenciales 2018-2020 01 ANTIBACTERIANOS PARA USO SISTÉMICO No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Mexico. Cuadro Basico de Medicamentos - 2017 06. ENFERMEDADES INFECCIOSAS Y PARASITARIAS No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 J. ANTI-INFECCIOSOS PARA USO SISTEMICO No observations
El Salvador - 2019 ANTIBACTERIANOS Others observations:
In vancomycin resistance
Haiti. National List of Essential Medicines 06.02.02 Other Antibacterials No observations
Bahamas. Drug Formulary 7.01.02. Other Antibacterials No observations
PAHO Strategic Fund Medicine List 2.4. Antiberculosis med. 2nd line Others observations:
Procurement of this medicine through the Strategic Fund should be limited for use according to WHO recommended M/XDR-TB regimen in patients for whom there are few or no treatments available. Patients receiving this medicine should be monitored for potential adverse events or related toxicities through national pharmacovigilance programs and data from the WHO Programme for International Drug Monitoring (UPPSALA).

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 6.2.5. Antituberculosis medicines This medicine requires a children care specialist.
PAHO Strategic Fund Medicine List 2.4. Antiberculosis med. 2nd line No observations

Information Resources: Linezolid

Loading ...
Loading ...
Loading ...
No information available